Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2010
07/08/2010US20100174076 Coumarin derivatives useful as tnf alpha inhibitors
07/08/2010US20100173998 Odor controlled personal care compositions containing hydroxypropyl trialkylammonium salts
07/08/2010US20100173997 2,4,6-trisubstituted phenols having anesthetic properties
07/08/2010US20100173995 Use of PPAR-alpha activator as inflammatory skin disease-treating agent and method for treating skin diseases using the same
07/08/2010US20100173994 Synthesis of triethylenetetramines
07/08/2010US20100173992 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
07/08/2010US20100173991 Method for the synthesis of a-ring aromatized acetyl minocyclines
07/08/2010US20100173990 Transglutaminase Inhibitor Comprising Chlorogenic Acid And A Method For Producing Thereof
07/08/2010US20100173988 Oxaliplatin active substance with a very low content of oxalic acid
07/08/2010US20100173986 Sesquiterpenes and derivatives thereof for use as feed additives
07/08/2010US20100173985 Polyphenol proteasome inhibitors, synthesis, and methods of use
07/08/2010US20100173984 Epigallocatechin-3-gallate crystal compositions
07/08/2010US20100173983 Method for inducing autophagy
07/08/2010US20100173982 Novel method for the asymmetric synthesis of beta-lactone compounds
07/08/2010US20100173981 Therapeutic compounds
07/08/2010US20100173980 Antiviral oligonucleotides targeting rsv
07/08/2010US20100173979 Gene therapy for lysosomal storage diseases
07/08/2010US20100173978 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
07/08/2010US20100173977 Crystal
07/08/2010US20100173976 RNA INTERFERENCE MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
07/08/2010US20100173975 Expressed Pseudogene Regulates Gene Expression
07/08/2010US20100173974 Extended dicer substrate agents and methods for the specific inhibition of gene expression
07/08/2010US20100173973 Extended dicer substrate agents and methods for the specific inhibition of gene expression
07/08/2010US20100173972 Methods and uses related to rhbdl4
07/08/2010US20100173971 Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer
07/08/2010US20100173970 C-nitroso-derived nitroxyl donors
07/08/2010US20100173969 Therapeutic agent
07/08/2010US20100173968 Sub-type selective azabicycloalkane derivatives
07/08/2010US20100173967 Use of spiro-oxindole compounds as therapeutic agents
07/08/2010US20100173964 Pharmaceutical composition that includes a dipeptidyl peptidase-iv inhibitor
07/08/2010US20100173963 Compound
07/08/2010US20100173961 Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors
07/08/2010US20100173960 The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
07/08/2010US20100173958 Compounds for the inhibition of dgat1 activity
07/08/2010US20100173957 Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy
07/08/2010US20100173956 Use of Quaternary Pyridinium Salts as Vasoprotective Agents
07/08/2010US20100173955 4-substituted phenoxyphenylacetic acid derivatives
07/08/2010US20100173954 Treatment of cancers having resistance to chemotherapeutic agents
07/08/2010US20100173953 4-[4-(amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrate
07/08/2010US20100173952 Metalloprotein inhibitors
07/08/2010US20100173951 Novel methods
07/08/2010US20100173949 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
07/08/2010US20100173947 New Indications for Direct Thrombin Inhibitors
07/08/2010US20100173946 Benzimidazolylidene propane-1,3-dione derivative or salt thereof
07/08/2010US20100173945 Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof
07/08/2010US20100173944 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
07/08/2010US20100173942 Phosphodiesterase 4 inhibitors
07/08/2010US20100173941 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia
07/08/2010US20100173940 Non-mucoadhesive film dosage forms
07/08/2010US20100173939 Antiviral compounds
07/08/2010US20100173938 Nerve cell death inhibitor
07/08/2010US20100173937 Use of tetrakis-quaternary ammonium salts as pain modulating agents
07/08/2010US20100173936 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system-related disorders
07/08/2010US20100173935 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia
07/08/2010US20100173934 Combinations of therapeutic agents for treating cancer
07/08/2010US20100173933 Antibacterial agents
07/08/2010US20100173932 Sub-type selective amides of diazabicycloalkanes
07/08/2010US20100173931 Harmine derivatives for reducing body weight
07/08/2010US20100173930 Certain Chemical Entities, Compositions and Methods
07/08/2010US20100173929 Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof
07/08/2010US20100173928 Phosphorylation and regulation of AKT/PKB by the rictor-mTOR complex
07/08/2010US20100173927 administering 2,3,4,4a,13b-hexahydro-2,10-dimethyldiben-[2,3:6,7]oxepino[4,5c]pyridine-4a-ol] for treating pain associated with surgery, inflammation, cancer and neuropathic pain; pain management
07/08/2010US20100173926 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
07/08/2010US20100173925 Oxyindole derivatives
07/08/2010US20100173924 Novel heterocycle compounds and uses thereof
07/08/2010US20100173923 4 (pyrrolopyridinyl)pyrimidinyl-2-amine derivatives
07/08/2010US20100173922 Polymorphisms for Predicting Disease and Treatment Outcome
07/08/2010US20100173921 Antiretroviral Solid Oral Composition
07/08/2010US20100173919 Pharmaceutical composition using aliskiren and avosentan
07/08/2010US20100173918 Methods and compositions for determining the efficacy of breast cancer therapeutics
07/08/2010US20100173917 Urea derivatives as abl modulators
07/08/2010US20100173916 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
07/08/2010US20100173915 Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound
07/08/2010US20100173914 Pharmaceuticals, compositions and methods of making and using the same
07/08/2010US20100173913 Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents
07/08/2010US20100173912 Novel Compound
07/08/2010US20100173911 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES
07/08/2010US20100173910 Triaminopyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors
07/08/2010US20100173909 Piperidine compounds and uses thereof - 596
07/08/2010US20100173908 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
07/08/2010US20100173907 Method of treatment of aggression
07/08/2010US20100173906 Substituted 3,4,6,7-Tetrahydro-5H-1,2a,4a,8-Tetraazacyclopenta[cd]Phenalenes and Methods
07/08/2010US20100173905 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
07/08/2010US20100173904 Topical composition, topical composition precursor, and methods for manufacturing and using
07/08/2010US20100173903 Bicyclic amide derivatives for the treatmet of respiratory disorders
07/08/2010US20100173902 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
07/08/2010US20100173901 Substituted Heterocyclic Compounds
07/08/2010US20100173899 Dipeptide analogs as coagulation factor inhibitors
07/08/2010US20100173898 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof
07/08/2010US20100173897 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
07/08/2010US20100173896 Organic Compounds
07/08/2010US20100173895 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose)polymerase(parp)
07/08/2010US20100173894 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
07/08/2010US20100173893 Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation
07/08/2010US20100173892 Enantioselective synthesis of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-JK][1]-benzazepin-2[1H]-one and zilpaterol
07/08/2010US20100173891 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
07/08/2010US20100173890 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease
07/08/2010US20100173889 Substituted Pyrimidine and Triazine Compounds
07/08/2010US20100173888 Nicotinamide Derivatives
07/08/2010US20100173887 Bactericidal anti-mrsa active pharmaceutical composition containing carbapenems
1 ... 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 ... 7860